Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.04. | Nordhealth AS - Annual Financial Statements for 2023 | 2 | Oslo Børs | ||
21.03. | Nordhealth AS - Primary insider notice | 2 | Oslo Børs | ||
05.03. | Nordhealth AS: Q4 and second half 2023 interim financial report | - | Oslo Børs | ||
23.02. | Nordhealth AS - Invitation to Q4 2023 presentation | - | Oslo Børs | ||
09.01. | Nordhealth AS: Nordhealth Finland receives ISO/IEC 27001:2022 certification, applying highest standards of security to customer data | 1 | Oslo Børs | ||
29.12.23 | Nordhealth AS - Primary insider notices | - | Oslo Børs | ||
22.12.23 | Nordhealth AS - Primary insider notices | - | Oslo Børs | ||
06.12.23 | Nordhealth AS: Results of Share Buy Back | 1 | Oslo Børs | ||
30.11.23 | Nordhealth AS: Initiating Offer To Buy Back Own Shares | 1 | Oslo Børs | ||
16.11.23 | Nordhealth AS - Primary insider notice | - | Oslo Børs | ||
14.11.23 | Nordhealth AS: Q3/2023 results and CMD presentation | - | Oslo Børs | ||
09.11.23 | Nordhealth AS: Financial calendar | - | Oslo Børs | ||
06.11.23 | Reminder: Nordhealth AS to host Capital Markets Day on 14 November 2023 | 1 | Oslo Børs |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 75,48 | +0,08 % | Medtronic's Inceptiv Spinal Cord Stimulator Receives FDA Approval To Treat Chronic Pain | FRIDLEY (dpa-AFX) - Friday, Medtronic plc (MDT) announced that the FDA has approved its Inceptiv closed-loop rechargeable spinal cord stimulator to treat chronic pain. The company said this... ► Artikel lesen | |
M1 KLINIKEN | 13,650 | +2,63 % | EQS-Adhoc: M1 Kliniken AG beschließt Aktienrückkauf | EQS-Ad-hoc: M1 Kliniken AG / Schlagwort(e): Aktienrückkauf
M1 Kliniken AG beschließt Aktienrückkauf
26.04.2024 / 11:06 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17... ► Artikel lesen | |
CARDINAL HEALTH | 97,14 | +1,19 % | Peering Into Cardinal Health's Recent Short Interest | ||
RESMED | 199,80 | -1,33 % | Kurs der ResMed-Aktie verharrt auf Vortags-Niveau (189,60 €) | CODE Der jüngste Kurs betrug 189,60 Euro. Kaum auffällig ist zur Stunde am Aktienmarkt der Kurs von ResMed. Das Papier liegt mit 10,88 Prozent im Plus, verglichen mit der Schlussnotierung vom Vortag.... ► Artikel lesen | |
MCKESSON | 505,00 | +0,88 % | McKesson declares $0.62 dividend | ||
ZIMMER BIOMET | 111,00 | -2,25 % | SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings? | ||
CO-DIAGNOSTICS | 1,030 | -7,21 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
CLARIANE | 2,244 | -0,36 % | Clariane: First Quarter 2024 Revenue | Solid business growth in the first quarter of 2024: revenue up 7.4% All regions and business segments contributing to growth Refinancing Plan well underway in the first quarter:
... ► Artikel lesen | |
LIMES SCHLOSSKLINIKEN | 346,00 | 0,00 % | Limes Schlosskliniken erwartet Zuwachs bei Umsatz und EBITDA | Die Kölner Limes Schlosskliniken AG meldet für 2023 einen Anstieg der Gesamterträge um 26 Prozent auf 37,4 Millionen Euro. Vor Zinsen und Steuern sinkt der Gewinn um 22 Prozent auf 4,7 Millionen Euro... ► Artikel lesen | |
MOLINA HEALTHCARE | 321,20 | +0,16 % | Molina Healthcare Reports First Quarter 2024 Financial Results | LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted... ► Artikel lesen | |
LANTHEUS | 62,62 | -0,19 % | Lantheus Holdings, Inc. - 8-K, Current Report | ||
IZOTROPIC | 0,086 | +19,11 % | EQS-News: Izotropic Corporation: Izotropic erhält Antwort von der US-Behörde FDA | EQS-News: Izotropic Corporation
/ Schlagwort(e): Miscellaneous
Izotropic erhält Antwort von der US-Behörde FDA
31.01.2024 / 18:58 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
INSPIREMD | 1,840 | 0,00 % | InspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update | - Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 - - Announced positive 30-day data from the Company's ongoing U.S. Investigational Device... ► Artikel lesen | |
ASTRANA HEALTH | 33,800 | +1,20 % | Astrana Health, Inc. - 8-K, Current Report | ||
RESHAPE LIFESCIENCES | 0,162 | 0,00 % | ReShape Lifesciences Inc: ReShape Lifesciences Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update | Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference... ► Artikel lesen |